Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin

被引：0
|
作者：
Nathaniel Eraikhuemen
Daniel Julien
Alandra Kelly
Taylor Lindsay
Dovena Lazaridis
机构：
[1] Florida A&M University College of Pharmacy and Pharmaceutical Sciences,Department of Pharmacy
[2] Institute of Public Health,undefined
[3] Memorial Regional Hospital South,undefined
[4] Memorial Regional Hospital,undefined
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
BC-3781; Community-Acquired pneumonia; Clinical pharmacology; Lemafulin; Mechanism of action;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Lefamulin is the first pleuromutilin antibiotic approved for the treatment of bacterial infections in humans. Pleuromutilin antibiotics exert their unique mechanism of action which makes them less susceptible to the development of bacterial resistance and low probability of cross-resistance to the other antimicrobial classes.
引用
收藏
页码：149 / 163
页数：14
相关论文
共 50 条
  • [31] Community-acquired pneumonia: Diagnosis and treatment
    Sinaniotis, CA
    PEDIATRIC PULMONOLOGY, 1999, : 144 - 145
  • [32] Diagnosis and treatment of community-acquired pneumonia
    Lutfiyya, MN
    Henley, E
    Chang, LF
    Reyburn, SW
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (03) : 442 - 450
  • [33] Levofloxacin in the treatment of community-acquired pneumonia
    Léophonte, P
    Veyssier, P
    PRESSE MEDICALE, 1999, 28 (36): : 1975 - 1979
  • [34] Levofloxacin in the treatment of community-acquired pneumonia
    Noreddin, Ayman M.
    Elkhatib, Walid F.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (05) : 505 - 514
  • [35] New treatment for community-acquired pneumonia
    不详
    INFECTIONS IN MEDICINE, 2003, 20 (04) : 206 - +
  • [36] Linezolid in the treatment of community-acquired pneumonia
    Kaplan, SL
    Patterson, L
    Edwards, KM
    Azimi, PH
    Bradley, JS
    Blumer, JL
    Lobeck, FG
    Stalker, DJ
    Anderson, DC
    PEDIATRIC RESEARCH, 2000, 47 (04) : 266A - 266A
  • [37] Preventing and Treating Community-Acquired Pneumonia: A Focus on Men
    Sarbacker, G. Blair
    Threatt, Tiffaney
    Gordon, Martin
    US PHARMACIST, 2018, 43 (08) : 21 - 25
  • [38] Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
    File, Thomas M., Jr.
    Goldberg, Lisa
    Das, Anita
    Sweeney, Carolyn
    Saviski, John
    Gelone, Steven P.
    Seltzer, Elyse
    Paukner, Susanne
    Wicha, Wolfgang W.
    Talbot, George H.
    Gasink, Leanne B.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) : 1856 - 1867
  • [39] Community-acquired pneumonia
    Roaf, E
    LANCET, 1998, 352 (9145): : 2019 - 2019
  • [40] Community-Acquired Pneumonia
    Wunderink, Richard G.
    Waterer, Grant W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (06): : 543 - 551
12345